After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$242.28K

Mokari Atabak Chief Financial Officer

Transaction date Jul 30, 2026
Public filing date Aug 3, 2026
Filing lag Filed 4 days later

CORT daily price context

Close on/before transaction
$118.32 Jul 30, 2026
First close after public filing
$109.8 Aug 4, 2026
30-day return after filing
+0.57% Through Sep 2, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
2,202 shares @ $110.03
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001193125-26-330668
Filing cohort

Transactions in this filing

Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$11.02M
Buys / sales
0 / 13
Transactions reported in the same official filing
Issuer Transaction Traded Value
Corcept Therapeutics Inc CORT Exercise Jul 30, 2026 $1.84M
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $443.25K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $957.89K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $43.38K
Corcept Therapeutics Inc CORT Current Sale Jul 30, 2026 $242.28K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $66.57K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $531.94K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $1.78M
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $1.65M
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $829.1K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $974.95K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $567.91K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $971.94K
Corcept Therapeutics Inc CORT Sale Jul 30, 2026 $120.8K
Corcept Therapeutics Inc CORT Exercise Jul 30, 2026 $0